Eton Pharmaceuticals (ETON) EBIAT: 2019-2025
Historic EBIAT for Eton Pharmaceuticals (ETON) over the last 7 years, with Sep 2025 value amounting to -$1.9 million.
- Eton Pharmaceuticals' EBIAT fell 407.34% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.7 million, marking a year-over-year decrease of 21.91%. This contributed to the annual value of -$3.8 million for FY2024, which is 308.44% down from last year.
- Per Eton Pharmaceuticals' latest filing, its EBIAT stood at -$1.9 million for Q3 2025, which was up 25.45% from -$2.6 million recorded in Q2 2025.
- In the past 5 years, Eton Pharmaceuticals' EBIAT registered a high of $5.1 million during Q1 2021, and its lowest value of -$6.1 million during Q3 2021.
- Over the past 3 years, Eton Pharmaceuticals' median EBIAT value was -$1.6 million (recorded in 2025), while the average stood at -$985,727.
- Per our database at Business Quant, Eton Pharmaceuticals' EBIAT soared by 392.62% in 2023 and then slumped by 407.34% in 2025.
- Quarterly analysis of 5 years shows Eton Pharmaceuticals' EBIAT stood at $1.0 million in 2021, then declined by 12.22% to $912,000 in 2022, then tumbled by 347.37% to -$2.3 million in 2023, then soared by 73.49% to -$598,000 in 2024, then tumbled by 407.34% to -$1.9 million in 2025.
- Its EBIAT stands at -$1.9 million for Q3 2025, versus -$2.6 million for Q2 2025 and -$1.6 million for Q1 2025.